Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify" style="text-align:justify;">WOODCLIFF LAKE, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has adopted an...